Once-daily dosing of HAART: do the benefits outweigh the concerns?
Monier
Paul
P
Section of Clinical Medicine, LSU Health Sciences Center, USA.
D023241:Antiretroviral Therapy, Highly Active; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage
D018894:Reverse Transcriptase Inhibitors